Skip to content
CancerIndex

Publication

Role of radiotherapy in refractory/relapsed classical Hodgkin lymphoma in the era of targeted therapies and immunotherapy.

Sukeina Baouia, Rafik Nebbache, Côme Bommier, Florian Chevillon, Emmanuel Fardeau, Catherine Thieblemont, Laurent Quero

Clinical and translational radiation oncologySep 1, 2026PMID 42388465doi:10.1016/j.ctro.2026.101221 PMC13320509Journal ArticleReviewpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260908-000002
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Relapsed or refractory classical Hodgkin lymphoma (R/R cHL) remains a complex therapeutic challenge despite major advances in systemic treatment. Salvage therapy followed by autologous stem cell transplantation (ASCT) remains the standard of care for eligible patients, but contemporary…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.